PROGASTRIN-RELEASING PEPTIDE (PROGRP) IN THE DIFFERENTIAL DIAGNOSTICS OF LUNG CARCINOMA

被引：0
|
作者：
Dastych, M. [1 ]
Tomiskova, M. [2 ,3 ]
Klabenesova, I. [1 ]
Skrickova, J. [2 ,3 ]
机构：
[1] Fac Hosp Brno, Dept Clin Biochem, Brno, Czech Republic
[2] Masaryk Univ, Fac Med, Dept Lab Methods, Brno, Czech Republic
[3] Masaryk Univ, Fac Med, Dept Pulm Dis & Tberculosis, Brno, Czech Republic
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [31] Progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA expression in non-tumor tissues of the human gastrointestinal tract
    Hans-Jürg Monstein
    Niclas Grahn
    Mikael Truedsson
    Bodil Ohisson
    World Journal of Gastroenterology, 2006, (16) : 2574 - 2578
  • [32] Comment on "Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report"
    Qiu, Zijin
    Huang, Huanhuan
    Zhang, Yingxiao
    Chen, Deqing
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : E138 - E139
  • [33] An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival
    Korse, C. M.
    Taal, B. G.
    Bonfrer, J. M. G.
    Vincent, A.
    van Velthuysen, M. L.
    Baas, P.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2625 - 2630
  • [34] Comment on "Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report" Response
    Nisman, Benjamin
    Oleinikov, Kira
    Nechushtan, Hovav
    Maimon, Ofra
    Atlan, Karine
    Peled, Nir
    Gross, David
    Peretz, Tamar
    Meirovitz, Amichay
    Grozinsky-Glasberg, Simona
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : E139 - E141
  • [35] Choice of serum tumor markers in patients with small cell lung cancer: progastrin-releasing peptide, neuron-specific enolase, and carcinoembryonic antigen
    Huang LiSi
    Yan HaiYan
    Sun LongQiaoZi
    Xu Ying
    Cai DongHao
    Li XiaoHui
    Chen XinLiang
    Luo XiaoHong
    Duan ChaoHui
    生物组学研究杂志（英文）, 2018, 1 (01)
  • [36] Detection of micro dissemination of cancer cells by testing for progastrin-releasing peptide expression in the peripheral blood of SCLC patients
    Kimura, Hideharu
    Kasahara, Kazuo
    CANCER RESEARCH, 2009, 69
  • [37] Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers (vol 35, 010702, 2025)
    Begolli, Gramos
    Lukic, Maja
    Rumora, Lada
    Corak, Lorna
    Dugac, Andrea Vukic
    Jakopovic, Marko
    Samarzija, Miroslav
    Tomas, Ilijan
    Knezevic, Jelena
    Debeljak, Zeljko
    BIOCHEMIA MEDICA, 2025, 35 (01)
  • [38] Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer
    Yamaguchi, Hiroyuki
    Soda, Hiroshi
    Kitazaki, Takeshi
    Nakano, Hirofumi
    Fujino, Satoru
    Nakamura, Yoichi
    Kohno, Shigeru
    RESPIROLOGY, 2007, 12 (01) : 137 - 139
  • [39] Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients
    Yashi, M
    Muraishi, O
    Kobayashi, Y
    Tokue, A
    Nanjo, H
    PROSTATE, 2002, 51 (02): : 84 - 97
  • [40] Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide
    Qader, Abed Abdel
    Urraca, Javier
    Torsetnes, Silje Boen
    Tonnesen, Finn
    Reubsaet, Leon
    Sellergren, Boerje
    JOURNAL OF CHROMATOGRAPHY A, 2014, 1370 : 56 - 62
12345